Dapagliflozin Shows Promise in Treating MASH and Liver Fibrosis: BMJ-Published Chinese Trial Offers New Hope

A recent clinical trial in China, published in The BMJ, has revealed that dapagliflozin, a drug commonly used to treat type 2 diabetes, shows significant potential in treating metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis—two progressive liver conditions with limited current treatment options. 🔬 About the Study Participants’ body weight, blood sugar, liver enzymes, blood…

भोपाल में 2025 का पहला कोविड-19 केस मिला, डॉक्टरों ने दी सावधानी बरतने की सलाह

भोपाल में मंगलवार (3 जून 2025) को 42 वर्षीय महिला की कोविड-19 रिपोर्ट पॉजिटिव आई है, जो इस साल का शहर में पहला पुष्ट मामला है। महिला को बुखार और गले में खराश की शिकायत पर ओपीडी में दिखाने के बाद टेस्ट की सलाह दी गई थी। शाम 7:17 बजे उसकी RT-PCR रिपोर्ट पॉजिटिव आई।…

WHO Issues First-Ever RSV Immunization Guidelines to Protect Infants from Deadly Infections

The World Health Organization (WHO) has released its first official position paper on immunization against Respiratory Syncytial Virus (RSV) — a critical step in the fight against a disease responsible for nearly 100,000 deaths and 3.6 million hospitalizations each year among children under five. The paper, published in the Weekly Epidemiological Record, outlines evidence-based strategies…

IASST Scientists Discover Promising Drug Strategy for Neurodegenerative Diseases

A team of researchers at the Institute of Advanced Study in Science and Technology (IASST), an autonomous body under the Department of Science and Technology (DST), has made significant progress in the search for effective treatments for neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. In a recent study published in the journal Drug Discovery…

Switch Language »